The scrip opened at Rs 955.0 and touched an intraday high and low of Rs 961.1 and Rs 951.6, respectively, in the session so far. Shares of the company of Lupin Ltd. quoted a 52-week high of Rs 1267.5 and a 52-week low of Rs 856.0.
Total market cap of the Lupin Ltd. stood at Rs 43436.23 crore at the time of writing this report.
Key Financials
The company reported consolidated net sales of Rs 4298.02 crore for the quarter ended 30-Jun-2021, up 11.89 per cent from previous quarter’s Rs 3841.32 crore and up 20.35 per cent from the year-ago quarter’s Rs 3571.14 crore.
The net profit for latest quarter stood at Rs 542.46 crore, up 407.45 per cent from the same quarter a year ago.
Shareholding pattern
As of 30-Jun-2021, domestic institutional investors held 11.43 per cent stake in the firm, while foreign institutional investors held 18.6 per cent and the promoters 46.84 per cent.
Valuation ratio
According to BSE data, the stock traded at a P/E multiple of 26.29 and a price-to-book ratio of 3.36. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Lupin Ltd. belongs to the Pharma – Indian industry.
